Cash, cash equivalents, restricted cash, and available-for-sale marketable securities

3 Months Ended

Mar. 31, 2020

Cash, cash equivalents, restricted cash, and available-for-sale marketable securities

Cash, cash equivalents, restricted cash, and available-for-sale marketable securities

4. Cash, cash equivalents, restricted cash, and available-for-sale marketable securities

Cash, cash equivalents, and marketable securities included the following at March 31, 2020 and December 31, 2019:

	Amortized		Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
	(in thousands)
As of March 31, 2020
Money market funds included in cash and cash equivalents	$	153,395	$	—	$	—	$	153,395
Marketable securities:
U.S. Treasury notes		85,154		550		—		85,704
Equity securities		1,220		212		—		1,432
Total marketable securities	$	86,374	$	762	$	—	$	87,136
Total money market funds and marketable securities	$	239,769	$	762	$	—	$	240,531
As of December 31, 2019
Money market funds included in cash and cash equivalents	$	78,303	$	—	$	—	$	78,303
Marketable securities:
U.S. Treasury notes		195,467		52		28		195,491
Equity securities		1,220		700		—		1,920
Total marketable securities	$	196,687	$	752	$	28	$	197,411
Total money market funds and marketable securities	$	274,990	$	752	$	28	$	275,714

All of the Company’s marketable debt securities at March 31, 2020, have a contractual maturity of one year or less.

The following table provides a reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows:

	As of March 31,
	2020		2019
	(in thousands)
Cash and cash equivalents	$	165,227	$	113,261
Restricted cash included in deposits and other non-current assets		1,779		735
Total cash, cash equivalents, and restricted cash	$	167,006	$	113,996